RSS
Glialign
Glialign receives investment to develop novel cell therapy
The UCL Technology Fund (UCLTF) and UK Innovation & Science Seed Fund (UKI2S), with support from Innovate UK, have invested in cell therapy company Glialign — a spin out company from UCL. Read more